InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Free Cash Flow (2016 - 2026)

InflaRx (IFRX) posted Free Cash Flow of -$8.6 million for Q1 2026, down 50.47% sequentially from -$5.7 million in Q4 2025, and up 41.33% YoY from -$6.1 million in Q1 2025.

InflaRx (IFRX) Free Cash Flow (2016 - 2026) Analysis & Trends

InflaRx has reported Free Cash Flow for 11 years, with the latest figure at -$8.6 million in Q1 2026.

  • Quarterly Free Cash Flow rose 41.33% year-over-year to -$8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.4 million (up 34.77% YoY) and the FY2025 annual result came in at -$40.0 million, up 23.91% from the prior year.
  • Free Cash Flow eased to -$8.6 million in Q1 2026 per IFRX's latest filing, from -$5.7 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$3.2 million in Q3 2022 and troughed at -$16.1 million in Q1 2024.
  • A 5-year average of -$10.5 million and a median of -$11.3 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2022 and 2023: Free Cash Flow jumped 72.88% in 2022, then sank 128.74% in 2023.
  • Over 5 years, Free Cash Flow stood at -$5.2 million in 2022, then tumbled by 128.74% to -$11.8 million in 2023, then declined by 8.07% to -$12.8 million in 2024, then surged by 55.1% to -$5.7 million in 2025, then slumped by 50.47% to -$8.6 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$8.6 million, -$5.7 million, and -$10.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn -2.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.64 Mn
Mar 31, 2026 -8.64 Mn
Dec 31, 2025 -5.74 Mn
Dec 31, 2025 -5.74 Mn
Sep 30, 2025 -10.47 Mn
Sep 30, 2025 -10.47 Mn
Jun 30, 2025 -8.53 Mn
Jun 30, 2025 -8.53 Mn
Mar 31, 2025 -14.73 Mn
Mar 31, 2025 -14.73 Mn
Dec 31, 2024 -12.79 Mn
Dec 31, 2024 -12.79 Mn
Sep 30, 2024 -10.61 Mn
Sep 30, 2024 -10.61 Mn
Jun 30, 2024 -13.05 Mn
Jun 30, 2024 -13.05 Mn
Mar 31, 2024 -16.13 Mn
Mar 31, 2024 -16.13 Mn
Dec 31, 2023 -11.84 Mn
Dec 31, 2023 -11.84 Mn